9Heng DMK,Wee J,Fong KW,et al. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer, 1999,86 : 1912-1920.
10Ma J, Mai HQ, Hong MH, et al. Is the 1997 AJCC stage system for nasopharyngeal carcinoma prognostically useful for Chinese patient populations?. Int J Radiat Oncol Biol Phys ,2001,50 : 1181-1189.
2Lee KC, Chan6 HH, Chung YH, et aI. Andrographolide acts as an anti inflammatory agent in LPS stfmulated EAW264.7macrophages by inhibiting STAT3-mediated suppression of the NF-kappaB pathway[J]. J Ethnopharmaco], 2011 , 155(5):678--684.
3Pratheeshkumar P, Kuttan G, Andrographolide inhibits human umbilical vein endothelial cell invasion andmigration by regulating MMP- 2 and MMP-9 during angfogenesis[J].J Environ Pathol Toxicol Oncol, 2011,30(1):33-4],.
5De Paoli P. Novel vitally targeted therapies of EBV-associated tumors[J]. Curt Cancer Drug Targets, 2008,8(7):591--596.
6Chung C, Mader CC, Schmitz JC, et al. The vacuolar-ATPase modufates matrix metaUoproteinese isoforms in humanpancreatfc cancer[J]. Lab Invest, 201i,91(5):732--743.
7Garcia- Fmmunohistochemical in oralsquamous ce 2012,87(2): 133--1 Garcia A, Perez-Sayans GM, godriguez M J, et a[. ]ocalfzation of CI subunit of V-ATPase (ATPase C1) I cancer and normal oral mucosa[J]. Biotech Histochem, 39.
8ltajasekaran SA, Huynh TP, Wolle DG, et al. Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancerand fibrosis[J]. Mol Cancer Ther, 2010,9(6):1515-1524.
98anchez--Oenizo L, Formentini L, Aidea M, et a;. Up--regulation of the ATPase inWbitory factor (IFI) of the mitochondrial H+--ATPsynthase in human tumors mediates the metabolic shift of cancer cells to aWarburg phenotype[J]. J Biol Chem, 2010,285(55):25308-253]3.
10Huang KH, Chow KC, Chang HW, et al. ATPase family AAA domain containing 5A is an anti-apoptotic factor and asecretion reguiatoF of PSA in prostate cancer[J], lnt J Mol Med, 201],28(1):9-]5,.
